Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance

Cell Cycle

Volumn 11, Issue 22, 2012, Pages 4174-4180

  Salem, Ahmed F ^a,b,c   Whitaker Menezes, Diana ^a,b   Howell, Anthony ^d   Sotgia, Federica ^a,b,d,e   Lisanti, Michael P ^a,b,d,e  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NATIONAL ORGANIZATION FOR DRUG CONTROL AND RESEARCH NODCAR   (Egypt)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Angiogenesis; Autophagy resistance; Cancer metabolism; Mitochondrial biogenesis; Oxidative phosphorylation; OXPHOS; Two compartment tumor metabolism

Indexed keywords

CD31 ANTIGEN; METFORMIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1BETA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOPHAGY; BIOGENESIS; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; COMPLEX FORMATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MITOCHONDRIAL BIOGENESIS; MITOCHONDRIAL RESPIRATION; ONCOGENE; OXIDATIVE PHOSPHORYLATION; PROMOTER REGION; QUANTITATIVE ANALYSIS; STARVATION; TUMOR GROWTH;

EID: 84869438139     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.22376     Document Type: Article

References (36)

1. Ward PS, Thompson CB. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012; 21:297-308; PMID:22439925; http://dx.doi.org/10.1016/j.ccr.2012.02.014.
2. Warburg O. On the origin of cancer cells. Science 1956; 123:309-14; PMID:13298683; http://dx.doi.org/10.1126/science.123.3191.309.
3. Salem AF, Whitaker-Menezes D, Lin Z, Martinez-Outschoorn UE, Tanowitz HB, Al-Zoubi MS, et al. Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 2012; 11:2545-56; PMID:22722266; http://dx.doi.org/10.4161/cc. 20920.
4. Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: supporting cells "fuel" cancer cell mitochondria. Cell Metab 2012; 15:4-5; PMID:22225869; http://dx.doi.org/10.1016/j.cmet.2011.12.011.
5. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial "lactate shuttle"in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10:1772-83; PMID:21558814; http://dx.doi.org/10.4161/cc.10.11.15659.
6. Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, et al. Evidence for a stromal-epithelial "lactate shuttle"in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 2011; 10:1772-83; PMID:21558814; http://dx.doi.org/10.4161/cc.10.11.15659.
7. Colca JR, McDonald WG, Waldon DJ, Leone JW, Lull JM, Bannow CA, et al. Identification of a novel mitochondrial protein ("mitoNEET") cross-linked specifically by a thiazolidinedione photoprobe. Am J Physiol Endocrinol Metab 2004; 286:E252-60; PMID:14570702; http://dx.doi.org/10.1152/ ajpendo.00424.2003.
8. Wiley SE, Murphy AN, Ross SA, van der Geer P, Dixon JE. MitoNEET is an iron-containing outer mitochondrial membrane protein that regulates oxidative capacity. Proc Natl Acad Sci USA 2007; 104:5318-23; PMID:17376863; http://dx.doi.org/10.1073/pnas.0701078104.
9. Liu C, Lin JD. PGC-1 coactivators in the control of energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2011; 43:248-57; PMID:21325336; http://dx.doi.org/10.1093/abbs/gmr007.
10. Scarpulla RC. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim Biophys Acta 2011; 1813:1269-78; PMID:20933024; http://dx.doi.org/10.1016/j.bbamcr.2010.09.019.
11. Lin J, Puigserver P, Donovan J, Tarr P, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1beta (PGC-1beta ), a novel PGC-1-related transcription coactivator associated with host cell factor. J Biol Chem 2002; 277:1645-8; PMID:11733490; http://dx.doi.org/10.1074/jbc.C100631200.
12. Arnold JJ, Smidansky ED, Moustafa IM, Cameron CE. Human mitochondrial RNA polymerase: structurefunction, mechanism and inhibition. Biochim Biophys Acta 2012; 1819:948-60; PMID:22551784; http://dx.doi.org/10.1016/j.bbagrm.2012.04. 002.
13. Wanrooij S, Falkenberg M. The human mitochondrial replication fork in health and disease. Biochim Biophys Acta 2010; 1797:1378-88; PMID:20417176; http://dx.doi.org/10.1016/j.bbabio.2010.04.015.
14. Scarpulla RC. Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev 2008; 88:611-38; PMID:18391175; http://dx.doi.org/10.1152/physrev.00025.2007.
15. Whitaker-Menezes D, Martinez-Outschoorn UE, Flomenberg N, Birbe RC, Witkiewicz AK, Howell A, et al. Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue. Cell Cycle 2011; 10:4047-64; PMID:22134189; http://dx.doi.org/10.4161/cc.10.23.18151.
16. Wenz T, Rossi SG, Rotundo RL, Spiegelman BM, Moraes CT. Increased muscle PGC-1alpha expression protects from sarcopenia and metabolic disease during aging. Proc Natl Acad Sci USA 2009; 106:20405-10; PMID:19918075; http://dx.doi.org/10.1073/pnas.0911570106.
17. Asin-Cayuela J, Gustafsson CM. Mitochondrial transcription and its regulation in mammalian cells. Trends Biochem Sci 2007; 32:111-7; PMID:17291767; http://dx.doi.org/10.1016/j.tibs.2007.01.003.
18. Salem AF, Whitaker-Menezes D, Lin Z, Martinez-Outschoorn UE, Tanowitz HB, Al-Zoubi MS, et al. Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 2012; 11:2545-56; PMID:22722266; http://dx.doi. org/10.4161/cc.20920.
19. Martinez-Outschoorn UE, Sotgia F, Lisanti MP. Power surge: supporting cells "fuel" cancer cell mitochondria. Cell Metab 2012; 15:4-5; PMID:22225869; http://dx.doi.org/10.1016/j.cmet.2011.12.011.
20. Fogal V, Richardson AD, Karmali PP, Scheffler IE, Smith JW, Ruoslahti E. Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation. Mol Cell Biol 2010; 30:1303-18; PMID:20100866; http://dx.doi.org/10.1128/MCB.01101-09.
21. Funes JM, Quintero M, Henderson S, Martinez D, Qureshi U, Westwood C, et al. Transformation of human mesenchymal stem cells increases their dependency on oxidative phosphorylation for energy production. Proc Natl Acad Sci USA 2007; 104:6223-8; PMID:17384149; http://dx.doi.org/10.1073/pnas.0700690104.
22. Handschin C, Spiegelman BM. Peroxisome proliferator-activated receptor gamma coactivator 1 coactivators, energy homeostasis, and metabolism. Endocr Rev 2006; 27:728-35; PMID:17018837.
23. Deblois G, Chahrour G, Perry MC, Sylvain-Drolet G, Muller WJ, Giguère V. Transcriptional control of the ERBB2 amplicon by ERRalpha and PGC-1beta promotes mammary gland tumorigenesis. Cancer Res 2010; 70:10277-87; PMID:20961995; http://dx.doi.org/10.1158/0008-5472.CAN-10-2840.
24. Shiota M, Yokomizo A, Tada Y, Inokuchi J, Tatsugami K, Kuroiwa K, et al. Peroxisome proliferator-activated receptor gamma coactivator-1alpha interacts with the androgen receptor (AR) and promotes prostate cancer cell growth by activating the AR. Mol Endocrinol 2010; 24:114-27; PMID:19884383; http://dx.doi.org/10.1210/me.2009-0302.
25. Chen SD, Yang DI, Lin TK, Shaw FZ, Liou CW, Chuang YC. Roles of Oxidative Stress, Apoptosis, PGC-1αand Mitochondrial Biogenesis in Cerebral Ischemia. Int J Mol Sci 2011; 12:7199-215; PMID:22072942; http://dx.doi.org/10. 3390/ijms12107199.
26. St-Pierre J, Drori S, Uldry M, Silvaggi JM, Rhee J, Jäger S, et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006; 127:397-408; PMID:17055439; http://dx.doi.org/10.1016/j.cell.2006.09.024.
27. Ritov VB, Menshikova EV, He J, Ferrell RE, Goodpaster BH, Kelley DE. Deficiency of subsarcolemmal mitochondria in obesity and type 2 diabetes. Diabetes 2005; 54:8-14; PMID:15616005; http://dx.doi.org/10.2337/diabetes.54.1. 8.
28. Kelley DE, He J, Menshikova EV, Ritov VB. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002; 51:2944-50; PMID:12351431; http://dx.doi.org/10.2337/diabetes.51.10.2944.
29. Rabøl R, Boushel R, Almdal T, Hansen CN, Ploug T, Haugaard SB, et al. Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes. Diabetes Obes Metab 2010; 12:806-14; PMID:20649633; http://dx.doi.org/10.1111/j.1463-1326. 2010.01237.x.
30. Mensink M, Hesselink MK, Russell AP, Schaart G, Sels JP, Schrauwen P. Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 alpha and PPAR beta/delta gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int J Obes (Lond) 2007; 31:1302-10; PMID:17310221; http://dx.doi.org/10.1038/sj.ijo.0803567.
31. Arnold JJ, Smidansky ED, Moustafa IM, Cameron CE. Human mitochondrial RNA polymerase: structurefunction, mechanism and inhibition. Biochim Biophys Acta 2012; 1819:948-60; PMID:22551784; http://dx.doi.org/10.1016/j.bbagrm.2012.04. 002.
32. Fusté JM, Wanrooij S, Jemt E, Granycome CE, Cluett TJ, Shi Y, et al. Mitochondrial RNA polymerase is needed for activation of the origin of light-strand DNA replication. Mol Cell 2010; 37:67-78; PMID:20129056; http://dx.doi.org/10.1016/j.molcel.2009.12.021.
33. Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010; 10:98; PMID:20230646; http://dx.doi.org/10.1186/1471-2407-10-98.
34. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402:672-6; PMID:10604474; http://dx.doi.org/10.1038/45257.
35. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100:15077-82; PMID:14657337; http://dx.doi.org/10.1073/pnas.2436255100.
36. Bonuccelli G, Casimiro MC, Sotgia F, Wang C, Liu M, Katiyar S, et al. Caveolin-1 (P132L), a common breast cancer mutation, confers mammary cell invasiveness and defines a novel stem cell/metastasis-associated gene signature. Am J Pathol 2009; 174:1650-62; PMID:19395651; http://dx.doi.org/10.2353/ajpath. 2009.080648.